Hospitals with greater reductions in readmissions rates are no more likely to increase their observation-service use than other hospitals, according to a study reported today in the New England Journal of Medicine. The study examines readmission and observation-service rates before, during and after implementation of the Affordable Care Act and its Hospital Readmissions Reduction Program. “Within hospitals, there was no significant association between changes in observation-service use and changes in readmission rates after implementation of the ACA,” the authors write. The study also found that readmission rates were falling before ACA implementation, declined more quickly after implementation and then at a slower rate after HRRP penalties were initiated. “This study from Department of Health and Human Services researchers shows America’s hospitals have reduced avoidable readmissions and continue to improve,” said AHA President and CEO Rick Pollack. “It also disproves the notion that the reduction in readmissions has led to an increase in observation stays, instead attributing that increase to the overzealous Recovery Audit Contractors who second-guess physician judgment.”

Headline
March 8-14 marks Patient Safety Awareness Week. The AHA has several resources including podcasts, videos and reports that show how AHA members are advancing…
Headline
The U.S. District Court for the Southern District of Florida March 6 ruled in favor of five Florida hospitals in a case challenging the methodology used by the…
Chairperson's File
Public
This week, March 8-14, is Patient Safety Awareness Week. Delivering safe, quality care to all patients is the top priority for everyone working in hospitals…
Headline
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus…
Headline
Thomas McGinn, M.D., senior executive vice president and chief physician executive officer at CommonSpirit Health, shares how the organization aligns…
Headline
The Food and Drug Administration Feb. 3 released an early alert on a heart pump issue from certain Abiomed products. The agency said Abiomed found its Impella…